PRAX
PRAX clinical trials: Praxis Precision Medicines, Inc.
Every trial on ClinicalTrials.gov where Praxis Precision Medicines, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 17
- Trials linked
- 17
- As lead sponsor
- 0
- As collaborator
- 3
- Primary completions as lead sponsor, next 90 days
PRAX on the catalyst calendar · PRAX registry changes
- Primary completion Oct 10, 2025ActualPhase 3NCT06087276Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)Praxis Precision Medicines · Essential TremorRecruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 14, 2026ActualPhase 2/Phase 3NCT06999902Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)Praxis Precision Medicines · Focal SeizureCompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimatePhase 3NCT07505004Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresPraxis Precision Medicines · Focal EpilepsyActive, not recruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2028Sponsor estimatePhase 3NCT07287163Clinical Trial of Vormatrigine in Adult Patients With EpilepsyPraxis Precision Medicines · Epilepsy, Tonic-ClonicEnrolling by invitationPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 3NCT07019922A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyPraxis Precision Medicines · Epileptic EncephalopathyRecruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 3NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutriginePraxis Precision Medicines · Developmental and Epileptic Encephalopathy 1Active, not recruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 5, 2025ActualPhase 1NCT06840925A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628Praxis Precision Medicines · HealthyCompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2026ActualPhase 1/Phase 2NCT05737784A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathyPraxis Precision Medicines · SCN2A-DEEActive, not recruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 12, 2025ActualPhase 2/Phase 3NCT05818553A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)Praxis Precision Medicines · SCN2A EncephalopathyActive, not recruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2025Sponsor estimatePhase 2NCT06908356An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresPraxis Precision Medicines · Focal Onset SeizureRecruitingPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 9, 2023ActualPhase 2NCT05021991A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential TremorPraxis Precision Medicines · Essential TremorCompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 24, 2022ActualPhase 2NCT05021978A Clinical Trial of PRAX-944 in Participants With Essential TremorPraxis Precision Medicines · Essential TremorCompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2023ActualNo phase registeredNCT05407727A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic EncephalopathyPraxis Precision Medicines · SCN2A-DEECompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2022ActualPhase 2NCT05387642A Clinical Trial of PRAX-114 in Participants With Essential TremorPraxis Precision Medicines · Essential TremorWithdrawnPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2022ActualPhase 2NCT05260541A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress DisorderPraxis Precision Medicines · Post-traumatic Stress DisorderTerminatedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2022ActualPhase 2NCT04969510A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive DisorderPraxis Precision Medicines · Major Depressive DisorderCompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 5, 2022ActualPhase 2/Phase 3NCT04832425A Clinical Trial of PRAX-114 in Participants With Major Depressive DisorderPraxis Precision Medicines · Major Depressive DisorderCompletedPRAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 17 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner